All News

Smoking is a major cause of cancer in the United States, but data from a recent study show that talking to a nurse may help some patients quit the habit.

Last night's "In Our Genes: An Evening of Storytelling" was an event that not only raised money for research in BRCA-related cancers, but also aimed to raise the spirits of individuals who have been affected by the gene mutation.

Immunotherapy agents have shown significant promise in treating non-small cell lung cancer (NSCLC) in the second line, but what will their future be in lung cancer's frontline?

Managing emotions can be difficult, but it's important to treasure what you have while you have it.

Today I feel as if I have some unfinished business, though I am not quite sure what it is.

Winson Cheung, M.D., medical oncologist at the British Columbia Cancer Agency in Vancouver, discusses the importance of discussing any immunotherapy-related side effects with health care providers.

From promising new therapies to risk prediction, the field of lung cancer care is rapidly evolving. CURE spoke with Corey J. Langer, M.D., to get some updates.

Mita Patel urges patients not to rush to the conclusion that a lump in the breast means cancer. However, it should definitely be checked out by a doctor.

Surgical choices are difficult, but being informed helps make them easier.

A cancer diagnosis can evoke many emotions. It may, indeed, be too much to grasp.

While planning to start her family, Carmen Phaneuf learned that a cancer diagnosis may be in her future. Now, the multiple myeloma survivor urges others to live each day to the fullest.

Findings from a recent trial found that Kyprolis did not improve progression free survival (PFS) in transplant ineligible patients with newly diagnosed multiple myeloma.

Catching this bug of helping patients with cancer just may be the healthiest thing you can do.

Life, with or without cancer, is about learning to let go of all that we can't control, and focusing on what we can control.

Some men with cancer may feel more comfortable discussing their diagnosis over a couple of beers than in a more formal support group. M Powerment is here to help.

There have been some exciting advances in using immunotherapy to treat GU malignancies such as kidney and bladder cancer. CURE sat down with Elizabeth Plimack, M.D. to discuss them.

Cancer causes changes, but it doesn't change identity.

Adding the antipsychotic agent Zyprexa improved the prevention of nausea for patients receiving highly emetogenic chemotherapy.

A recent study found a correlation between frequent cervical cancer screenings and decreased mortality.

Encapsulated follicular variant of papillary thyroid cancer may actually not be cancer at all, according to Yuri E. Nikiforov.

Immunotherapy may not end up being as successful in treating sarcoma as it is in other types of cancer, says Katherine Thornton M.D.

The approval of Keytruda for metastatic head and neck squamous cell carcinoma is just the beginning when it comes to treating head and neck cancer with immunotherapy.

CURE spoke with an expert on the future of treating triple-negative breast cancer, including the potential for immunotherapy, targeted therapy and AR-targeted agents.

Anti-androgen therapies may eventually be used to treat some patients with breast cancer, according to Tiffany A. Traina, M.D.

Teen Cancer America partners with hospitals throughout the United States to develop specialized facilities and services for teens and young adults with cancer.